EP3268490
SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE-CONTAINING COMBINATIONS
:
EP einkaleyfi: Þýðing ekki lögð inn:
7.3.2016:
8.7.2020:
16710115.3
:
6.3.2036
:
SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE-CONTAINING COMBINATIONS
7.3.2016
8.7.2020
:
Bayer Pharma Aktiengesellschaft:
Müllerstrasse 178, 13353 Berlin, DE
:
Bayer Healthcare Pharmaceuticals Inc.:
100 Bayer Boulevard, Whippany, New Jersey 07981, US
:
LIU, Ningshu:
12203 Berlin, DE
:
PENA, Carol:
Basking Ridge, New Jersey 07920, US
:
JEFFERS, Michael:
Ridgewood, New Jersey 07450, US
:
GENVRESSE, Isabelle:
10627 Berlin, DE
:
201562130418 P:
9.3.2015:
US
:
EP2016054727:
7.3.2016
:
C12Q 1/68, A61K 31/519, A61K 31/53, A61K 45/06, A61P 35/00